Dr. Karl Ljungberg

Dr. Karl Ljungberg has an extensive experience of immunology, virology and particularly vaccinology from Karolinska Institutet, University of North Carolina and Public Health Agency of Sweden. Dr. Ljungberg holds a M.Sc. in Molecular Biology from Stockholm University and a Ph.D. in Infectious Disease Control from Karolinska Institutet.

Read More

Ms. Sandra Jeldes Granstrand

Sandra Jeldes Granstrand, Director of CMC Development, Chemistry Manufacturing and Control, graduated as Master of Engineering, specialized in Bio-Medical Technology. Previously Deputy Head of Laboratory and CMC at Newron.

Read More

Dr. Hans Arwidsson

Dr. Hans Arwidsson, President, CEO and Board Director, is an executive with broad cross-functional experience from the pharmaceutical industry, e.g. Astra and AstraZeneca. Arwidsson holds a M.Sc. and a Ph.D. in pharmaceutical sciences from Uppsala University as well as an Executive MBA from Stockholm School of Economics.

Read More

Do you want to follow Eurocine Vaccines development?

Share our ambition developing more effective vaccines. Fill in your e-mail address and we will update you with the latest Press Releases and Stories.

Start your subscription here »